Skip to main content

Table 2 Dietary intakes of study participants before the intervention

From: Metabolic and hormonal effects of melatonin and/or magnesium supplementation in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial

Variables

The study groups

P

Placebo (n = 20)

Melatonin + Mg (n = 22)

Melatonin (n = 21)

Mg (n = 21)

Energy (Kcal)

1325.66 ± 252.63

1277.90 ± 273.18

1449.01 ± 400.07

1256.00 ± 396.07

0.259

Carbohydrate (g)

191.75 ± 47.68

176.08 ± 41.24

195.69 ± 58.17

174.78 ± 59.92

0.116

Protein (g)

48.87 ± 14.12

46.80 ± 14.77

58.02 ± 16.71

49.64 ± 17.54

0.461

Fat (g)

40.90 ± 13.82

43.76 ± 15.87

48.79 ± 15.97

40.93 ± 17.17

0.336

PUFA (g)

5.88 (1.06, 28.47)

7.59 (0.87, 24.66)

7.68 (1.92, 20.01)

6.42 (1.33, 22.70)

0.593

MUFA (g)

11.93 ± 5.11

12.75 ± 5.95

14.73 ± 5.86

11.97 ± 6.64

0.386

SFA (g)

13.71 ± 5.01

13.08 ± 5.19

16.97 ± 8.43

12.44 ± 6.77

0.120

  1. Data are are Means ± SD and Geometric Means (Min, Max)
  2. P values based on One-Way ANOVA test or Kruskal–Wallis test
  3. PUFA polyunsaturated fatty acid, MUFA monounsaturated fatty acid, SFA saturated fatty acid